Skip navigation

Tracking Emerging State Price Transparency, Reporting & Disclosure Laws to Ensure Compliance

May 10, 2018
  • Philadelphia, PA

State drug pricing regulations remain in the headlines as state legislatures across the nation continue to introduce and pass laws aimed at transparency and reporting obligations leaving many unanswered questions and a myriad of legislative and compliance complexities. Are you prepared for the impact on drug pricing and compliance practices?

Over the past year, states including California, Nevada, Maryland, New York, Massachusetts, Vermont, Ohio and Illinois, have introduced and/or enacted different laws and enforcement initiatives mandating the disclosure of drug pricing increases, introducing restrictions limiting Medicaid drug spending, requiring disclosure of company metrics and expenses, and other related pricing ballot initiatives.

CBI’s 2nd Annual One-day Drug Pricing Transparency Congress Features the Following Sessions:

  • The Latest Developments in State Pricing Transparency Landscape
    — Preparing for Additional Legislative Activity in 2018
  • Exploring the Legal and Enforcement Implications of State Pricing
    and Transparency Laws
  • State-by-State Analysis —
    What You Need to Know Now to Ensure Reporting Compliance
  • State Waivers and Future Legal Implications
  • And much more!

Don’t miss this timely event — register today!